Bergonie Institute Breast Cancer Database

Breast Cancer Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02893761
• Other study ID #: IB BASE SEIN
• Status: Active, not recruiting
• Phase: N/A
• First received: August 18, 2016
• Last updated: November 10, 2017
• Start date: January 1990

Study information

• Verified date: November 2017
• Source: Institut Bergonié
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A database of breast cancer patients was established at Institute Bergonié since the 90s , to assess patients' survival, assess practice, search for prognostic factors.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 21439
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Breast cancer

• Aged 18 years and over

• First treatment at Bergonie Institute

Exclusion Criteria:

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Institut Bergonié

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall Survival		5 years
Primary	Overall Survival		10 years
Secondary	Distant disease-free survival	D-DFS, distant disease-free survival, as defined following DATECAN guidelines (Gourgou et al. Annals Oncol 2015). D-DFS is defined as the time to death or appearance/occurrence of metastases/distant recurrence, whichever occurs first	10 years